NCT01523340View on ClinicalTrials.gov

A Prospective Observational Study Evaluating c-MET Expression and EGFR Gene Mutation Correlation With Erlotinib Response

CompletedOBSERVATIONAL
Enrollment

196

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

September 30, 2014

Study Completion Date

November 30, 2017

Conditions
Non-small Cell Lung Cancer MetastaticNon-small Cell Lung Cancer Recurrent
Trial Locations (1)

58128

Chonnam National University Hwasun Hospital, Hwasun

All Listed Sponsors
collaborator

Roche Pharma AG

INDUSTRY

lead

Chonnam National University Hospital

OTHER

NCT01523340 - A Prospective Observational Study Evaluating c-MET Expression and EGFR Gene Mutation Correlation With Erlotinib Response | Biotech Hunter | Biotech Hunter